Metastop for dogs and koshek 50 tabs
Description
Verified seller “MY PET” (from Kiev) working on the portal Zakupka.com offers to buy Metastop for dogs and cats, 50 tabs Phytoelita
Phytoelita Metastop for dogs and cats, 50 tabs
Phytoelita Metastop is a drug for suppressing metastasis in cats and dogs.
Herbal medicinal product designed to prevent the spread of metastases and detoxify the body with neoplasms in cats and dogs:
prevention of metastasis in the pre and postoperative period;
prevention of oncological diseases upon detection of neoplasms;
genetic predisposition to oncology.
Description
Trade name: medicinal product: Phytoaelita® Metastop.
The drug is a biconvex tablet weighing 0.2 g from white to light yellow; inclusions and slight marbling are allowed. For oral administration.
Structure
Fitoelita® Metastop as active ingredients in 1 tablet contains extracts from plant raw materials: shiitake mushrooms, reishi mushrooms, broccoli embryos, chaga, oregano herb, horsetail herb, herb of the drugstore, shepherd’s purse herb, sandy immortelle flowers, real bedstraw herb, celandine herbs, nettle leaves, birch leaves, willow herb (willow-herb) narrow-leaved, St. John’s wort, Echinacea purpurea, comfrey roots, meadowsweet flowers, lemon balm herb, burdock roots, meadow clover flowers (red), roots and rhizomes licorice, marigold flowers, rhizomes and roots of burnet – 7.0 mg, with an amino nitrogen content of at least 0.5 μg.
Excipients: calcium stearate, starch and lactose.
Pharmacological properties
Fitoelita® Metastop refers to combined herbal medicines.
The mechanism of action of the drug is determined by the phytotherapeutic activity of biologically active substances of extracts from plant raw materials.
The polysaccharides contained in the shiitake mushroom, including lentinan, exhibit antitumor and antimetastatic activity. The carcinostatic effect of lentinan is mainly the result of the activation of perforin production. D-glucan binds to the surface layer of the lymphocyte or to a specific serum protein that activates macrophages, T cells, NK cells and other effector cells. This leads to an increase in the production of antibodies, interleukins (IL – 1 and IL – 2) and interferon (IFN). Polysaccharide KS – 2 also has antitumor properties due to the induction of interferon and stimulation of T-lymphocytes. The polysaccharide lanophil, contained in Reishi mushrooms, prevents the growth and metastasis of a wide range of tumors by activating macrophages and T-lymphocytes, stimulating the production of interferon. The pterins contained in chaga have a cytostatic effect and delay the initial stages of the tumor process. Arktigenin lignan aglycone (active ingredient of burdock) has direct antitumor activity. The indoles (diindolylmethane) of broccoli neutralize estrogens. Hanerol fireweed has a broad anticancer effect, including in breast cancer.
The glycoside tripolysin contained in clover has a pronounced antimetastatic effect by reducing the rate of capillary growth.
The medicinal product Fitoelita® Metastop – according to the degree of impact on the body, refers to low-hazard substances (hazard class 4 according to GOST 12. 1.007 – 76). The medicinal product does not possess cumulative, embryotoxic and teratogenic properties.
Application procedure
Fitoelita® Metastop is used for cats and dogs as an antimetastatic, antitoxic, antitumor and adaptogenic agent in the preoperative and postoperative periods, as well as for the purpose of detoxifying the body in case of neoplasms.
Fitoelita® Metastop is administered to animals individually orally in the following doses:
in the preoperative period 3 days before the operation – for dogs – 1 tablet per 10 kg of body weight, for cats – 1 tablet per animal 3 times a day;
in the postoperative period throughout the life of the animal every 3 months in courses of 7 days – for dogs 1 tablet per 10 kg of body weight, cats – 1 tablet per animal 3 times a day.
Contraindications
Individual hypersensitivity of the animal to the components of the drug.
Overdose
No symptoms of drug overdose
Application features
The peculiarities of the action of the drug at the first admission or at its cancellation have not been established.
There are no peculiarities of using the drug Fitoelita® Metastop for pregnant and lactating females.
If one or more doses of the drug are missed, treatment should be resumed as soon as possible in the prescribed dosage and regimen.
There is no information about the incompatibility of Fitoelita® Metastop with other drugs and (or) feed.
The drug is not intended for use in a productive